Press Releases
Abstract: In May 2020, French biotech firm Genfit delayed its Phase 3 NASH trial for elafibranor by 4-6 months due to slow patient recruitment, aiming
June 24, 2025
No Comments
Abstract: In May 2020, French biotech firm Genfit delayed its Phase 3 NASH trial for elafibranor by 4-6 months due to slow patient recruitment, aiming
Abstract: This article introduces the establishment of rheumatoid arthritis (RA) animal models by Jennio. RA is a chronic autoimmune disease with high teratogenic rate and
Abstract: This article introduces colon cancer orthotopic model construction and drug efficacy evaluation. With high global morbidity/mortality, the model inoculates luciferase-tagged MC38-Luc cells into mouse
Contact us via WeChat
Follow our Official Account